TScan Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TCRX and other ETFs, options, and stocks.About TCRX
TScan Therapeutics, Inc. discovers and develops transformative T cell therapies (TCR-T) to treat liquid cancers, solid tumors and other serious diseases. Its platform identifies previously uncharacterized, clinically-derived shared T cell antigens and all off-target TCR interactions, to enable the development of efficacious TCR-Ts.
TCRX Key Statistics
Stock Snapshot
TScan Therapeutics(TCRX) stock is priced at $1.09, giving the company a market capitalization of 62.02M. It carries a P/E multiple of -1.09.
On 2026-03-18, TScan Therapeutics(TCRX) stock traded between a low of $1.04 and a high of $1.15. Shares are currently priced at $1.09, which is +4.8% above the low and -5.2% below the high.
The TScan Therapeutics(TCRX)'s current trading volume is 333.64K, compared to an average daily volume of 774.69K.
In the last year, TScan Therapeutics(TCRX) shares hit a 52-week high of $2.57 and a 52-week low of $0.88.
In the last year, TScan Therapeutics(TCRX) shares hit a 52-week high of $2.57 and a 52-week low of $0.88.
Analyst ratings
83%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.